Novel biomarkers for risk of prostate cancer: results from a case-control study
- PMID: 18816637
- PMCID: PMC2588647
- DOI: 10.1002/pros.20850
Novel biomarkers for risk of prostate cancer: results from a case-control study
Abstract
Background: Although the estrogens estrone and estradiol are recognized to play very important roles in the risk of developing prostate cancer (Pca), the molecular mechanism by which estrogens initiate and/or promote Pca is still unknown. Substantial evidence supports that specific metabolites of estrogens, catechol estrogen quinones, can react with DNA to form depurinating estrogen-DNA adducts. Apurinic sites derived from depurination of these adducts can induce mutations leading to cancer. Once released from DNA, depurinating estrogen-DNA adducts are shed from cells into the bloodstream and excreted in urine. By analyzing profiles of estrogen metabolites, conjugates, and depurinating DNA adducts in urine from men with and without prostate cancer, potential biomarkers of Pca can be detected. The goal of this case-control study was to detect and identify potential biomarkers of Pca.
Methods: Urine samples from fourteen cases, men diagnosed with Pca, and 125 controls, men who had not been diagnosed with Pca, were partially purified by solid phase extraction and analyzed by ultraperformance liquid chromatography/tandem mass spectrometry. The urinary levels of androgens, estrogens, estrogen metabolites, conjugates and depurinating DNA adducts were measured.
Results: The ratio of depurinating estrogen-DNA adducts to the sum of the corresponding estrogen metabolites and conjugates was significantly higher in cases (median: 57.34) compared to controls (median: 23.39) (P < 0.001).
Conclusions: This study suggests that depurinating estrogen-DNA adducts could serve as potential biomarkers to predict risk of Pca. They also could be useful tools for early clinical diagnosis and development of suitable strategies to prevent Pca.
Copyright 2008 Wiley-Liss, Inc.
Figures
Similar articles
-
Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma.Biomarkers. 2009 Nov;14(7):502-12. doi: 10.3109/13547500903121715. Biomarkers. 2009. PMID: 19863189 Free PMC article.
-
Potential biomarker for early risk assessment of prostate cancer.Prostate. 2006 Oct 1;66(14):1565-71. doi: 10.1002/pros.20484. Prostate. 2006. PMID: 16894534
-
The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.Mol Aspects Med. 2014 Apr;36:1-55. doi: 10.1016/j.mam.2013.08.002. Epub 2013 Aug 30. Mol Aspects Med. 2014. PMID: 23994691 Free PMC article. Review.
-
The molecular etiology of breast cancer: evidence from biomarkers of risk.Int J Cancer. 2008 May 1;122(9):1949-57. doi: 10.1002/ijc.23329. Int J Cancer. 2008. PMID: 18098283 Free PMC article. Clinical Trial.
-
Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.Biochim Biophys Acta. 2006 Aug;1766(1):63-78. doi: 10.1016/j.bbcan.2006.03.001. Epub 2006 Apr 19. Biochim Biophys Acta. 2006. PMID: 16675129 Review.
Cited by 24 articles
-
Steroidomics for the Prevention, Assessment, and Management of Cancers: A Systematic Review and Functional Analysis.Metabolites. 2019 Sep 21;9(10):199. doi: 10.3390/metabo9100199. Metabolites. 2019. PMID: 31546652 Free PMC article. Review.
-
Role of Estrogen in Androgen-Induced Prostate Carcinogenesis in NBL Rats.Horm Cancer. 2019 Jun;10(2-3):77-88. doi: 10.1007/s12672-019-00360-7. Epub 2019 Mar 16. Horm Cancer. 2019. PMID: 30877616 Free PMC article.
-
Etiology and prevention of prevalent types of cancer.J Rare Dis Res Treat. 2017;2(3):22-29. doi: 10.29245/2572-9411/2017/3.1093. Epub 2017 May 2. J Rare Dis Res Treat. 2017. PMID: 30854528 Free PMC article.
-
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects.Chem Res Toxicol. 2017 Jan 17;30(1):13-37. doi: 10.1021/acs.chemrestox.6b00256. Epub 2016 Sep 29. Chem Res Toxicol. 2017. PMID: 27617882 Free PMC article.
-
Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention.Clin Transl Med. 2016 Mar;5(1):12. doi: 10.1186/s40169-016-0088-3. Epub 2016 Mar 15. Clin Transl Med. 2016. PMID: 26979321 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical